Delivering experienced investigators, diverse patient access, and disciplined trial execution in the heart of Scottsdale, Arizona.
Delivering experienced investigators, diverse patient access, and disciplined trial execution in the heart of Scottsdale, Arizona.
Scottsdale Clinical Trials is a dedicated Phase I through IV clinical research site in Scottsdale, Arizona, serving a diverse metropolitan patient population across the greater Scottsdale and Phoenix region. Led by board-certified principal investigator Dr. Todd Dreitzler, our site offers sponsors and CROs a reliable clinical research center in Scottsdale AZ backed by decades of clinical experience and a proven track record across pulmonology, cardiology, dermatology, endocrinology, sleep medicine, and ophthalmology.
As a proud member of ECN Clinical, Scottsdale Clinical Trials operates under centralized SOPs, unified contracting, and network-wide quality standards, giving sponsors and CROs the consistency of a national network with the accountability of a dedicated local site.
Scottsdale Clinical Trials conducts clinical research across six therapeutic areas led by board-certified principal investigator Dr. Todd Dreitzler. The site brings focused expertise in pulmonology clinical research, cardiology clinical research, and endocrinology clinical research in Scottsdale, alongside dermatology clinical research, sleep medicine clinical research, and ophthalmology clinical research in Scottsdale, Arizona.
Our patient recruitment infrastructure combines technology, community relationships, and dedicated outreach to deliver consistent enrollment performance across every study we support.
Scottsdale Clinical Trials serves a diverse adult patient population across Scottsdale and the greater Phoenix metropolitan region. Our location at 8997 E Desert Cove Ave gives participants throughout the Scottsdale area a convenient clinical research site near them, supported by flexible scheduling, transportation assistance, and a patient-first care model throughout every study.
Our Scottsdale location gives Scottsdale Clinical Trials access to one of Arizona's most diverse metropolitan communities. With a patient population that is 42% Hispanic, our bilingual English and Spanish site manager ensures every participant is fully informed and supported throughout their study journey.
Diversity in clinical research is a commitment to the communities we serve. Our sites are chosen and structured to reflect the communities they serve, ensuring every study benefits from genuine local representation, trust, and accessibility.
Download our network capability deck or TA-specific one-pagers to share with your team.
Yes. Scottsdale Clinical Trials offers paid clinical research opportunities in Scottsdale and across the greater Phoenix and Arizona region. Compensation varies by study and will be explained clearly before you enroll. Study-related medical care and visits are always at no cost to participants.
Scottsdale Clinical Trials is located at 8997 E Desert Cove Ave, Suite 2, Scottsdale, Arizona 85260, serving participants across a 40-mile catchment radius throughout the greater Scottsdale and Phoenix region.
Scottsdale Clinical Trials is a CLIA-certified clinical research site in Scottsdale AZ offering Phase I through IV capabilities. Our site features onsite ECG, cold chain and temperature-controlled drug storage, DEA license, CTMS and multiple EDC platforms, eConsent, Florence eISF for remote monitoring, and specialty procedures including biopsies, infusion, PK sampling, spirometry, oscillometry, FeNO, and certified FibroScan.
Scottsdale Clinical Trials conducts pulmonology clinical research, cardiology clinical research, endocrinology clinical research, dermatology clinical research, sleep medicine clinical research, and ophthalmology clinical research in Scottsdale, led by board-certified principal investigator Dr. Todd Dreitzler.
Yes. Scottsdale Clinical Trials is a dedicated clinical research site for sponsors and CROs, operating as part of the ECN Clinical under centralized SOPs, unified contracting, and network-wide quality standards. Sponsors and CROs benefit from a proven 85% screen to enroll rate, 91% patient retention rate, and startup timelines consistently under four weeks.
